Literature DB >> 12878154

Regulation of the HIV1 long terminal repeat by mutant heat shock factor.

Natalia A Ignatenko1, Eugene W Gerner.   

Abstract

Heat shock is a known transcriptional activator of human immunodeficiency virus type 1 (HIV1) long terminal repeat (LTR). However, HIV1 LTR suppression can occur under hyperthermic conditions. To investigate this phenomenon, a series of HIV1 LTR deletion luciferase constructs were generated and tested in cell culture in combination with a mutant heat shock factor 1 (HSF1+), which is transcriptionally active in the absence of heat stress. HSF1+ suppressed the activity of a minimal HIV1 LTR promoter, which contained NF-kappaB, Sp1, and tat consensus sequences. Electromobility shift assays showed nuclear protein-DNA complex formation with a Sp1 consensus sequence. Immunoprecipitation of nuclear extracts with Sp1 antibody did not affect nuclear protein-Sp1 oligonucleotide complex formation. In contrast, no complexes were formed with the Sp1 consensus sequence when the HSF protein was immunoprecipitated. These experiments indicate that modified heat shock factor can suppress HIV1 promoter activity by a mechanism involving interaction with Sp1 elements in the HIV1 promoter. The ability of HSF1+ to suppress HIV1 promoter activity suggests that HSF1+ could serve as a tool for the treatment of AIDS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878154     DOI: 10.1016/s0014-4827(03)00186-1

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  2 in total

1.  HSF1 Activation Can Restrict HIV Replication.

Authors:  Emmanuel E Nekongo; Anna I Ponomarenko; Mahender B Dewal; Vincent L Butty; Edward P Browne; Matthew D Shoulders
Journal:  ACS Infect Dis       Date:  2020-06-10       Impact factor: 5.084

2.  Cellular heat shock factor 1 positively regulates human immunodeficiency virus-1 gene expression and replication by two distinct pathways.

Authors:  Pratima Rawat; Debashis Mitra
Journal:  Nucleic Acids Res       Date:  2011-04-01       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.